Related Experiment Video

Updated: Jul 9, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 5, 2010

Enhanced theophylline metabolism in patients with bronchial asthma at age 4 and under

J Kizu1, M Arakawa, Y Arakawa

  • 1Department of Pharmacy, Branch Hospital, Faculty of Medicine, University of Tokyo, 3-28-6 Mejirodai, Bunkyo-ku, Tokyo 112-8688, Japan.

Biomedical Chromatography : BMC
|October 27, 1999
PubMed

Insights

Infants with asthma show higher theophylline metabolite levels, indicating faster drug metabolism in younger children. This suggests enhanced drug-metabolizing enzyme activity in infancy compared to older children.

Area of Science:

  • Pharmacology
  • Pediatrics
  • Biochemistry

Background:

  • Theophylline (TP) is a bronchodilator used for bronchial asthma.
  • Understanding theophylline metabolism is crucial for optimizing pediatric asthma treatment.
  • Age-related differences in drug metabolism can impact therapeutic efficacy and safety.

Purpose of the Study:

  • To investigate theophylline (TP) and its metabolite plasma levels in pediatric asthma patients.
  • To compare TP metabolism between different age groups (1-4 years vs. 5+ years).
  • To assess the influence of age on drug-metabolizing enzyme activity.

Main Methods:

  • Plasma samples were collected from bronchial asthma patients treated with slow-release theophylline.
  • Theophylline (TP) and its metabolite concentrations were quantified using analytical techniques.
  • Data were analyzed to compare metabolite-to-TP ratios across age groups.

Main Results:

  • Higher ratios of theophylline metabolites to TP were observed in children aged 1-4 years.
  • These ratios were significantly lower in the group aged 5 years and older.
  • The findings suggest a difference in metabolic clearance based on age.

Conclusions:

  • Infancy (1-4 years) is associated with enhanced theophylline metabolism compared to older children.
  • Drug-metabolizing enzyme activity appears to be higher in younger children.
  • These age-related metabolic differences may necessitate dosage adjustments in pediatric asthma therapy.

More Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

Related Concept Videos

Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...